Robert Gniadecki received his MD degree from Warsaw Medical School (Poland) in 1991 and three years later he obtained his PhD from the Faculty of Health Sciences at Copenhagen University (Denmark). In 2001 he became a specialist in dermatology (certified by the Danish National Board of Health) and in 2010 was appointed as a full clinical professor at the Department of Dermatology at Bispebjerg Hospital in Copenhagen. Dr Gniadecki has served as a president of the Danish Dermatological Society and a board member of the ESDR (European Society of Dermatological Research) and ISCL (International Society of Cutaneous Lymphomas). He is a member of several editorial boards including the Journal of the European Academy of Dermatology and Venerology and Dermatology. Dr Gniadecki published >200 papers. Among major clinical and scientific accomplishments are: development of the low-dose protocol of total skin irradiation for patients with cutaneous lymphomas, discovery of lymphoma stem cells and introduction of photophoresis and Mohs surgery to dermatology in Denmark. His current scientific activities focus on the experimental therapeutics of cutaneous lymphoma and melanoma and the clinical aspects of the biological treatment of psoriasis.
Translational research: cutaneous oncology with focus on pathogenesis and experimental therapy of cutaneous T-cell lymphomas and immunology of skin cancers.
Clinical research areas: biologic treatment of psoriasis, risk of skin cancer, radiotherapy and phototherapy of cutaneous T-cell lymphomas
Cutaneous lymphoma, genetics, exome sequencing
NATIENS: A Phase III randomized study to determine the mechanisms and optimal management of Stevens-Johnson syndrome and toxic epidermal necrolysis
- Funding Source: PAR-16-272 NIAID Clinical Trial Planning Grant (R34)
- Year Granted: 2017
Reaction diffusion reactions in skin diseases
- Funding Source: University of Alberta
- Year Granted: 2016
T-cell receptor repertoire in cutaneous T cell lymphoma
- Funding Source: Danish Cancer Foundation
- Year Granted: 2016